CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Grant or award Director acquired 26,250 shares (grant or award)
- 4 Open-market sale President and Head of R&D sold 4,092 shares at $6.90 ($28,250)
- 4 Open-market sale Chief Financial Officer sold 1,050 shares at $6.90 ($7,249)
- 4 Open-market sale Chief Medical Officer sold 2,617 shares at $6.90 ($18,067)
- 4 Open-market sale Chief Executive Officer sold 5,255 shares at $6.90 ($36,279)
- 4 Open-market sale Chief Executive Officer sold 15,186 shares at $6.22 ($94,428)
- 4 Open-market sale Chief Medical Officer sold 5,383 shares at an average $8.47 ($45,612)
- 4 Open-market sale President and Head of R&D sold 10,124 shares at $8.32 ($84,216)
- 4 Open-market sale Chief Financial Officer sold 1,291 shares at $8.32 ($10,739)
- 4 Open-market sale Chief Executive Officer sold 5,849 shares at $8.32 ($48,651)
- 4 Option exercise Director acquired 2,000 shares (option exercise)
- 4 Other disposition 10% owner disposed of 598,533 shares (other)
- 4 Other disposition Director disposed of 598,533 shares (other)
- 4 Grant or award Chief Development Officer acquired 21,576 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 35,702 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 20,047 shares (grant or award)
- 4 Grant or award President and Head of R&D acquired 80,365 shares (grant or award)
Page 7 of 16 · 301 filings